Suzuki Hidehiko, Kondoh Masuo, Yagi Kiyohito, Kiyono Hiroshi, Kunisawa Jun
Laboratory of Vaccine Materials, National Institute of Biomedical Innovation.
Yakugaku Zasshi. 2014;134(5):629-34. doi: 10.1248/yakushi.14-00006-3.
Most pathogens invade body through the mucosal epithelium, which is a primary target to prevent the infectious diseases. Mucosal vaccine has been considered to be an effective strategy to establish immunosurveillance against pathogens by the induction of antigen-specific immune responses at both mucosal and systemic immune compartments. The development of antigen delivery system and mucosal adjuvants are required for the sufficient induction of protective immunity in the development of mucosal vaccine. In this review, we shed light on the recent advances in the development of antigen delivery system using microbial functions for mucosal vaccines.
大多数病原体通过黏膜上皮侵入机体,黏膜上皮是预防传染病的主要靶点。黏膜疫苗被认为是一种有效的策略,可通过在黏膜和全身免疫区室诱导抗原特异性免疫反应来建立针对病原体的免疫监视。在黏膜疫苗的研发中,需要开发抗原递送系统和黏膜佐剂以充分诱导保护性免疫。在这篇综述中,我们阐述了利用微生物功能开发用于黏膜疫苗的抗原递送系统的最新进展。